Pancreatic Adenocarcinoma, Version 2.2014

Restricted access

The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize major discussion points from the 2014 NCCN Pancreatic Adenocarcinoma Panel meeting. The panel discussion focused mainly on the management of borderline resectable and locally advanced disease. In particular, the panel discussed the definition of borderline resectable disease, role of neoadjuvant therapy in borderline disease, role of chemoradiation in locally advanced disease, and potential role of newer, more active chemotherapy regimens in both settings.

Provided content development and/or authorship assistance.

Supplementary Materials

    • Supplemental Material (PDF 184 KB)
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 334 334 39
PDF Downloads 86 86 14
EPUB Downloads 0 0 0